SOTAC PHARMACEUTICALS LTD Share Price

SOTAC PHARMACEUTICALS LTD Share Price

NSE: SOTAC
|
Pharmaceuticals
|
S Cap
₹ 90.05
+0.00 (0.00%)
1D
Last updated 20 Aug, 2026, 11:13 IST

SOTAC PHARMACEUTICALS LTD Share Price Today

As of 23 Sep 2026, SOTAC PHARMACEUTICALS LTD share price is ₹90.05. The stock opened at ₹90.05, compared to its previous close of ₹90.05. During today's trading session, SOTAC PHARMACEUTICALS LTD share price moved in the range of ₹90.05 to ₹90.05, with an average price of ₹90.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹86.00 and a high of ₹139.65.

₹90.05
0.00% up today
₹90.05
1D LOW
1D HIGH

SOTAC PHARMACEUTICALS LTD Returns Calculator

Circuit
L
H
₹85.40
₹94.30
52-week
L
H
₹86.00
₹139.65

About SOTAC PHARMACEUTICALS LTD

SOTAC PHARMACEUTICALS LTD Share Price
ISIN
INE0O2D01012
Sector Market Cap
₹ 99.51 Cr

Sotac Pharmaceuticals Limited is an India-based pharmaceutical company. The Company's services include contract manufacturing, loan license, formulation and development (F & D) and research and development (R & D). It specializes in manufacturing a range of pharmaceutical products having a therapeutic portfolio including anti-diabetic, anti-psychotic, vitamins, minerals, iron, anti-cold, anti-allergic, dermatological products, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (IP-Lactams & Non-IP-Lactams), anti-fungal and cephalosporin. It also manufactures nutraceuticals products and food products on contract-manufacturing basis. Its products are supplied across 14 states in India, and it exports its products to over 20 countries worldwide. Its subsidiaries include Sotac Healthcare Private Limited, Sotac Lifesciences Private Limited and Sotac Research Private Limited.

SOTAC PHARMACEUTICALS LTD Financial Highlights

  • Revenue: SOTAC PHARMACEUTICALS LTD reported revenue of ₹101.59 crore in FY26 vs ₹100.89 crore in FY25. It showed an increase of 0.69% on a yearly basis.
  • Operating Profit: SOTAC PHARMACEUTICALS LTD reported an operating profit of ₹8.70 crore in FY26 vs ₹11.12 crore in FY25. It showed a decrease of 21.76% on a year-on-year basis.
  • Net Profit: SOTAC PHARMACEUTICALS LTD reported a net profit of ₹6.29 crore in FY26 vs ₹9.28 crore in FY25. It showed a decrease of 32.22% on a yearly basis.

SOTAC PHARMACEUTICALS LTD Quarterly Result Highlights

  • SOTAC PHARMACEUTICALS LTD reported revenue of ₹25.50 crore in Jun 2024, compared with ₹26.80 crore in Mar 2024, representing a decrease of 4.85% on a quarter-on-quarter (QoQ) basis.
  • SOTAC PHARMACEUTICALS LTD reported an operating profit of ₹1.30 crore in Jun 2024, compared with ₹0.30 crore in Mar 2024, representing an increase of 333.33% on a quarter-on-quarter (QoQ) basis.
  • SOTAC PHARMACEUTICALS LTD reported a profit of ₹1.35 crore in Jun 2024, compared with ₹1.51 crore in Mar 2024, reflecting a decrease of 10.60% on a QoQ basis.
  • The earnings per share (EPS) of SOTAC PHARMACEUTICALS LTD stood at ₹7.26 during Jun 2024.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.85%
FII
16.79%
Other DII
0.00%
Retail and other
10.36%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20248.88%
Mar 202515.12%
Sep 202516.14%
Mar 202616.79%
Mkt Cap Cr
99.51
P/E
—
P/B
—
ROE
—
D/E
0.00
ROCE
—
Div. Yield
0.00%
EPS(TTM)
4.45
Turnover
1.21
EV/EBITDA
—
Net Margin
0.00%
Op. Margin
0.00%
ROA
—
Quick Ratio
0.00
Curr. Ratio
0.00
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Sotac Pharma. has not beaten FD return of 7%
Step 3 of 5
Earnings
Neutral
Sotac Pharma. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SOTAC PHARMACEUTICALS LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2021
Revenue₹96.99₹103.83₹77.48₹48.84
Other Income₹3.90₹0.49₹0.35₹0.11
Total Revenue₹100.88₹104.32₹77.83₹48.95
Total Expenses₹89.76₹100.12₹74.49₹51.01
Profit Before Tax₹11.12₹3.96₹3.93-₹2.06
Tax₹1.84₹0.38₹1.64₹0.31
Profit After Tax₹9.28₹3.58₹2.29-₹2.37
EPS - Basic₹7.26₹3.90₹3.58-₹10.28
EPS - Diluted₹7.26₹3.90₹3.58-₹10.28

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2021
Profit before tax₹11.12₹3.96₹3.93-₹2.06
Income before WC changes₹17.38₹6.32₹8.25₹1.72
Change in Assets-₹11.04-₹19.77₹3.69-₹4.50
Change in Liabilities-₹9.87-₹0.94-₹2.12₹2.89
Change in WC-₹20.91-₹20.71₹1.57-₹1.61
Cash flow from Operations-₹4.33-₹16.08₹8.14-₹0.31
Cash flow from Investing-₹13.62-₹19.68-₹11.67-₹3.23
Cash flow from Financing₹16.09₹29.49₹13.14₹3.38
Total Cash Flow-₹1.85-₹6.26₹9.61-₹0.16
Cash (Start of the year)₹3.42₹9.68₹0.08₹0.43
Cash (End of the year)₹1.56₹3.42₹9.68₹0.27

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2021
Non-Current Assets₹54.50₹44.68₹26.50₹17.35
Current Assets₹69.83₹60.65₹47.14₹17.35
Total Assets₹124.33₹105.33₹73.64₹34.70
Current Liabilities₹51.55₹43.73₹45.81₹22.76
Net Current Asset₹18.28₹16.92₹1.33-₹5.41
Non-Current Liabilities₹14.36₹12.27₹8.14₹9.37
Equity Capital₹58.42₹49.33₹19.69₹2.57
Total Equity & Liabilities₹124.33₹105.33₹73.64₹34.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹62.38₹67.11₹57.98₹73.15
Other Income₹2.38₹1.32₹0.24₹0.21
Total Revenue₹64.76₹68.42₹58.23₹73.36
Total Expenses₹58.34₹60.43₹52.26₹68.67
Profit Before Tax₹6.41₹7.76₹5.96₹4.69
Tax₹1.64₹2.01₹1.47₹1.39
Profit After Tax₹4.77₹5.75₹4.50₹3.30
EPS - Basic₹4.32₹5.24₹5.58₹14.33
EPS - Diluted₹4.32₹5.24₹5.58₹14.33

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹6.41₹7.76₹5.96₹4.69
Income before WC changes₹8.50₹7.97₹8.35₹7.63
Change in Assets-₹8.35-₹19.10₹0.47-₹13.46
Change in Liabilities-₹5.43-₹6.93₹1.41₹10.84
Change in WC-₹13.78-₹26.02₹1.87-₹2.62
Cash flow from Operations-₹6.08-₹19.75₹8.54₹3.58
Cash flow from Investing-₹1.89-₹12.53-₹10.93-₹3.28
Cash flow from Financing₹7.78₹23.32₹11.97-₹0.30
Total Cash Flow-₹0.20-₹8.96₹9.57₹0.00
Cash (Start of the year)₹0.64₹9.60₹0.03₹0.02
Cash (End of the year)₹0.45₹0.64₹9.60₹0.03

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹30.40₹29.34₹18.18₹8.80
Current Assets₹54.90₹46.75₹36.61₹27.50
Total Assets₹85.29₹76.09₹54.78₹36.30
Current Liabilities₹26.49₹23.28₹27.11₹28.06
Net Current Asset₹28.40₹23.47₹9.49-₹0.56
Non-Current Liabilities₹5.77₹4.53₹6.68₹1.14
Equity Capital₹53.03₹48.27₹20.99₹7.10
Total Equity & Liabilities₹85.29₹76.09₹54.78₹36.30
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
48.44
Neutral
ATR (14)
3.12
Neutral
STOCH(9,6)
16.87
Bullish
STOCH RSI (14)
9.37
Bullish
ADX(9)
27.84
Bearish
UO(9)
31.22
Neutral
ROC(12)
-18.87
Bearish
WillR(14)
-83.8
Bullish
Period
Simple value
Exponential vaue
5D
90.98
91.64
10D
96.24
95.34
20D
102.32
99.89
50D
106.82
107.34
100D
115.44
0

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SOTAC PHARMACEUTICALS LTD Share Price
SOTAC PHARMACEUTICALS LTD
Pharmaceuticals
Add Stock
Add Another

SOTAC PHARMACEUTICALS LTD Share Price FAQs

SOTAC PHARMACEUTICALS LTD share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837